Availability of comparative trials for the assessment of new medicines in the European Union at the moment of market authorization.
SourceBritish Journal of Clinical Pharmacology, 63, 2, (2006), pp. 159-162
Article / Letter to editor
Display more detailsDisplay less details
British Journal of Clinical Pharmacology
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.